{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Assessing an Epidemic: Utility of the DSM-5 Level 2 Substance Use Screener in Adult Psychiatric Inpatients

Activity Steps

Purpose of Activity

To present the details of a study conducted to assess the utility of theDSM-5 Level 2 Substance Use screener as a supplemental tool for identifying substance use by self-report within an inpatient psychiatric hospital setting.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline the authors' purpose and goals for their study on the efficacy of the DSM-5 Level 2 Substance Use screener as a supplemental tool for identifying substance use by self-report within an inpatient psychiatric hospital setting.
  2. Summarize the results of the authors' study and any implications for practice.
Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • KY-BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: JAN0120
Published: Jan/Mar 2020
Expires: 12/31/2026
Required Passing Score: 16/18 (88%)
Authors: Matthew C. Sullivan, MS; Lauren Strainge, MS; Jaime E. Blackmon, MA; Stacy E. Cruess, PhD;David Wheeler, PhD; Dean G. Cruess, PhD